| Patent Number |
Title Of Patent |
Date Issued |
| 5686076 |
gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission |
November 11, 1997 |
| The present invention relates to a gD-negative Bovine Herpesvirus mutant, that has the property of direct cell-to-cell transmission. The invention also relates to a DNA-fragment capable of conferring this property to Bovine Herpesviruses, not possessing the direct cell-to-cell transmissi |
| 5684598 |
Process for monitoring a moving yarn sheet and apparatus for the execution of this process |
November 4, 1997 |
| Process for monitoring a moving yarn sheet by means of a light beam, photodetectors and an electronic analyzer, whereby the yarn sheet is guided via thread guide rods before and after the monitoring site and the shadowing of the light beam caused by an increase in thread thickness is |
| 5684145 |
Carrier system against GNRH |
November 4, 1997 |
| The present invention is concerned with vaccination of mammals against GnRH. The vaccine comprises a GnRH peptide conjugate to E. coli fimbrial-filaments and elicits an immune response against GnRH. |
| 5684116 |
Titanium dioxide/silicon dioxide coprecipitates and titanium dioxide/zirconium dioxide coprecipi |
November 4, 1997 |
| For the preparation of polyesters and copolyesters, titanium dioxide/silicon dioxide coprecipitates having a composition of TiO.sub.2 :SiO.sub.2 =90:10 to 20:80 mol/mol and/or titanium dioxide/zirconium dioxide coprecipitates having a composition of TiO.sub.2 : ZrO.sub.2 =95:5 to 70: |
| 5683511 |
Apparatus for applying liquid to a yarn sheet |
November 4, 1997 |
| An apparatus for applying a liquid to threads of a yarn sheet. The apparatus comprises multiple thread wetting elements, each of which has at least one thread guide groove for each thread. In the thread guide groove the thread travels with the liquid and each thread guide groove has one |
| 5681949 |
Alkyl glycoside and use thereof |
October 28, 1997 |
| In an alkyl glucoside of formula (I) R.sup.1 is an alkyl group having 2-5 carbon atoms, preferably 2-4 carbon atom; R.sup.2 is an alkyl group having 4-7 carbon atoms, preferably 5 or 6 carbon atoms, the sum of the carbon atoms in R.sup.1 and R.sup.2 being 7-11, preferably 7-9; G is a |
| 5679553 |
Process for rendering a nucleic acid amplication reaction product incapable of being a target fo |
October 21, 1997 |
| A process for making the product of a nucleic acid amplification reaction, which amplification reaction employs one or more primer pairs, incapable of being a target for further amplification comprising: contacting the amplified product with an oligonucleotide capable of hybridizing to a |
| 5679288 |
Blend of polyphosphate flame retardant and liquid crystalline additive |
October 21, 1997 |
| The disclosure teaches a blend of a predominant amount of a polyphosphate flame retardant and an effective amount of a liquid crystalline additive for viscosity reduction and compatibilization when blended with a thermoplastic polymer, as compared to use of just the polyphosphate flame |
| 5678326 |
Waterproof laminated shaped element and its application in shoes |
October 21, 1997 |
| A waterproof laminated shaped element used as an insert for shoes of a cement-lasted design, including an outer layer, an insole, a lining and a waterproof, water-vapour permeable laminate including a functional layer and optionally a support layer, where a border section of the lower ar |
| 5677438 |
Coccidiosis vaccine |
October 14, 1997 |
| The invention is concerned with a protein having the immunological properties of Eimeria tenella which is reactive with a monoclonal antibody E. TEN 11P-2 raised against E. tenella sporozoites.The invention also relates to polypeptide fragments of this protein which can be used for immun |
| 5674969 |
Rigid rod polymer based on pyridobisimidazole |
October 7, 1997 |
| A rigid rod polymer in which at least 50% of the recurring groups correspond to the formula; ##STR1## Included in the invention are processes for preparation of the above rigid rod polymer and using such polymer as well as compositions employing the above rigid rod polymer. |
| 5674500 |
Vaccines against Aujeszky's disease and other animal diseases containing pseudorabies virus muta |
October 7, 1997 |
| The invention provides vaccines for preventing and controlling animal diseases, comprising a pseudorabies virus containing glycoprotein gp50 and having a mutation in its gp50 gene. The vaccines are suitable for use against Aujeszky's disease (pseudorabies), or against other animal di |
| 5674499 |
Equine herpesvirus gene 15 mutants |
October 7, 1997 |
| The present invention relates to an Equine herpesvirus (EHV) vaccine comprising an EHV having an insertion or deletion in the gene 15 of the EHV genome. |
| 5670362 |
DNA encoding an Eimeria 100kD antigen |
September 23, 1997 |
| The invention is concerned with novel Eimeria proteins with immunogenic properties as well as with DNA sequences encoding these proteins. These proteins can be administered to chickens thereby protecting the chickens against coccidiosis. In addition the DNA encoding these proteins can be |
| 5668274 |
Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type |
September 16, 1997 |
| The invention relates to sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type, of which N-sulfate, N-acetate, and hydroxy groups, are replaced by alkoxy, aryloxy, aralkoxy, or O-sulfate groups. The compounds have antithrombotic and smooth muscle |
| 5667784 |
Tocols as adjuvant in vaccine |
September 16, 1997 |
| Oil based vaccines often cause serious local side effects at the site of administration and/or have a high viscosity which make said vaccines difficult to handle. Vaccines comprising as an adjuvant a stable emulsion of tocols in water do not display these undesired effects and induce goo |
| 5665545 |
Terminal repeat amplification method |
September 9, 1997 |
| This invention relates to a process for amplifying a specific nucleic acid sequence or its complement at a relatively constant temperature and without serial addition of reagents. The process provides in a single reaction medium an RNA polymerase, DNA polymerase, a ribonuclease that |
| 5663279 |
Ophthalmic lenses |
September 2, 1997 |
| The present invention relates to ophthalmic lenses with a refractive index from 1.50 to 1.51, which are the cured product of compositions comprising 60-99% wt % of at least one poly(allyl carbonate) of a polyhydroxy alcohol, said polyhydroxy alcohol having from 2 to 20 carbon atoms and |
| 5662936 |
Sugar-coated pharmaceutical dosage unit |
September 2, 1997 |
| The invention relates to sugar-coated dosage units comprising a steroid having two hydrogen atoms at position 3 of the steroid skeleton, such as desogestrel, allylestrenol, ethylestrenol, or lynestrenol, to a process for the manufacture of such dosage units, and a use of sugar-coated |
| 5661006 |
DNA encoding the Canine coronavirus spike protein |
August 26, 1997 |
| The invention is related to a nucleic acid sequence &coding a Canine coronavirus (CCV) spike protein. Such a protein can be used for the immunization of dogs against CCV infection. The nucleic acid sequence encoding the CCV spike protein can be applied for the preparation of the spik |
| 5660979 |
Detection of human retrovirus infection |
August 26, 1997 |
| A method for determining virus replication in human cells by human retrovirus using RNA amplification comprising detecting the hybridization of an RNA probe which specifically hybridizes with spliced RNA and not with genomic RNA. This method permits early detection of RNA replication |
| 5660910 |
Increased tear strength nonwoven fabric and process for its manufacture |
August 26, 1997 |
| A spun-bonded nonwoven composite web has randomly laid continuous matrix filaments (average linear density per filament less than 25 denier) and one or more continuous reinforcement filament (average linear density per filament which exceeds 20 denier and exceeds the average linear densi |
| 5657798 |
Intermingled synthetic filament yarn for manufacturing industrial woven fabrics |
August 19, 1997 |
| For producing woven fabrics for air bags and other industrial applications, an intermingled unsized synthetic filament yarn is used with a yarn titer of 100-1000 dtex. The individual filaments of the yarn have a titer not exceeding 5 dtex. The yarn exhibits a mean opening length of 2-10 |
| 5657156 |
Polymeric optical amplifier doped with lanthanide |
August 12, 1997 |
| The invention relates to a polymeric optical amplifier doped with lanthanide ions, which are present in the amplifier in the form of a complex.The invention also relates to novel electrically neutral lanthanide complexes which can be applied with advantage in the above-described poly |
| 5656597 |
Lyospheres comprising gonadotropin |
August 12, 1997 |
| The invention relates to lyospheres comprising gonadotropin, the preparation thereof, as well as pharmaceutical preparations containing the same. |
| 5654142 |
Method for nucleic acid amplification using inosine triphosphates to partially replace guanosine |
August 5, 1997 |
| The invention is an improved method for the amplification of nucleic acid, wherein ribonucleotides that weaken normal base pairing are introduced during amplification. Preferably, the ribonucleotides are inosine-triphosphate nucleotides which partly substitute guanine-triphosphate nu |
| 5652119 |
Recombinant feline herpesvirus vaccine |
July 29, 1997 |
| The present invention is concerned with a Feline herpesvirus (FHV) mutant comprising a heterologous gene introduced into an insertion-region of the FHV genome.The invention also relates to a vector vaccine comprising such an FHV mutant which expresses a heterologous polypeptide derived f |
| 5650155 |
Tocols as adjuvant in vaccine |
July 22, 1997 |
| Oil based vaccines often cause serious local side effects at the site of administration and/or have a high viscosity which make said vaccines difficult to handle. Vaccines comprising as an adjuvant a stable emulsion of tocols in water do not display these undesired effects and induce goo |
| 5648546 |
Method for manufacturing tert-butylamine |
July 15, 1997 |
| The invention relates to a method for manufacturing tert-butylamine from isobutene and ammonia in the presence of a silica alumina catalyst. The catalyst is in acid form, has an Si/Al ratio that has been adjusted by steam dealumination, has a crystallinity of at least 95%, and has an |
| 5648081 |
Actinobacillus pleuropneumoniae subunit vaccine |
July 15, 1997 |
| The present invention is concerned with vaccines effective in protecting pigs against porcine pleuropneumonia. Said vaccines comprising a hemolysin and/or macrophage toxin and a 42 kD OMP preparation derived from Actinobacillus pleuropneumoniae (App) cells induce a complete and heter |
| 5646046 |
Method and instrument for automatically performing analysis relating to thrombosis and hemostasi |
July 8, 1997 |
| This invention relates to a novel, fully automated spectrophotometric analyzer and method used for testing blood samples in the clinical laboratory for thrombosis and hemostasis properties. The analyzer tests samples in a fully randomized format, and is fully automated in the areas o |
| 5644041 |
Alkyl glycoside its use for cleaning purposes, and cleaning composition |
July 1, 1997 |
| The present invention generally relates to an alkyl glycoside of the formula (I): RCH.sub.2 O(G).sub.x H, wherein R is an alkyl group having a total of 8-12 carbon atoms and containing 2-4 groups of the formula --CH(CH.sub.3)-- in its carbon chain; G is a monosaccharide residue; and x |
| 5641471 |
Method for preparing .sup.213 Bi for therapeutic use |
June 24, 1997 |
| The present invention relates to the field of site directed therapy. More specifically it relates to site directed radio therapy. It provides a method for production of radioimmuno conjugates and an apparatus for radioimmuno therapy. The method, conjugates and apparatus can be practi |
| 5637487 |
Eimeria tenella vaccine |
June 10, 1997 |
| The invention is concerned with a polypeptide of Eimeria tenella which can be used for the immunization of chickens against coccidiosis.The invention also relates to a nucleic acid sequence encoding such a polypeptide. Said nucleic acid sequence is especially useful for the preparation o |
| 5635405 |
Aqueous colloidal dispersion for diagnostic tests |
June 3, 1997 |
| An aqueous colloidal dispersion for diagnostic or immunodiagnostic tests, comprising non-polymer nuclei surrounded by a hydrophilic copolymer that contains functional groups, a method for the detection of a specifically binding substance or immunochemically active component in a test flu |
| 5635345 |
Method for the diagnosis of HIV using antibodies to prosomes |
June 3, 1997 |
| This invention is directed to a method useful in the diagnosis of HIV. The method involves reacting monoclonal antibodies to particular prosomal proteins with certain blood cell types obtained from a sample, and observing an increase or decrease in the levels of the prosomal proteins |
| 5633301 |
Flame retardant polyketone composition |
May 27, 1997 |
| The present invention is a flame retardant polyketone polymer composition which comprises: (a) a bicyclic phosphorus flame retardant compound, such as one containing one or more pentaerythritol phosphate alcohol moieties, as exemplified by bis(pentaerythritol phosphate alcohol) carbonate |
| 5633072 |
Method of manufacturing a multilayer printed wire board |
May 27, 1997 |
| A process for manufacturing a multi-layer printed wire board, also referred to as a multilayer, comprising at least two electrically insulating substrates with electrically conductive traces or layers provided on at least three surfaces thereof, in which process, by means of lamination |
| 5628805 |
Ethanol fuel and the use of an ignition improver |
May 13, 1997 |
| The ignition of an aqueous ethanol fuel is essentially improved by using a water soluble adduct of a polyol having 3-10 hydroxyl groups and ethylene oxide and/or propylene oxide, the molecular weight of the adduct being 350-10,000. The fuel is in the form of a solution and contains 70-96 |
| 5626850 |
Non-shedding live herpesvirus vaccine |
May 6, 1997 |
| The present invention is concerned with a genetically modified live herpesvirus vaccine of which the live herpesviruses are not shed into the environment by a vaccinated animal. This can he achieved by deleting a gene encoding a gD homolog, such as gp50 of pseudorabies virus, and pro |
| 5622869 |
Method of detecting an obstruction in a fluid flow line of a medical laboratory instrument |
April 22, 1997 |
| An apparatus for detecting obstructions of a flow line. A detector housing is provided having a cavity therein. The detector housing has first and second openings into the cavity. The flow line is attached to the detector housing establishing a flow path through the first opening, the ca |
| 5622773 |
Process for plasma treatment of antiballistically effective materials |
April 22, 1997 |
| Two-stage process for plasma treatment of antiballistically effective materials such as aromatic polyamides. The first stage includes a plasma treatment with at least 50% inorganic gas or a mixture of inorganic gases, and the second phase includes a plasma treatment with a hydrophobicall |
| 5620966 |
11,21-bisphenyl-19-norpregnane derivatives |
April 15, 1997 |
| The invention relates to a 11,21-bisphenyl-19-norpregnane derivative of formula I ##STR1## wherein R.sub.1 is selected from H, halogen, (1-6C)alkoxy, and NR.sub.5 R.sub.6, R.sub.5 and R.sub.6 being independently hydrogen or (1-6C)alkyl or R.sub.5 and R.sub.6 together are (3-6C)al |
| 5620843 |
Non-A non-B sequences |
April 15, 1997 |
| A peptide within a non-A non-B hepatitis virus genome reacts with antibodies found in individuals infected with non-A non-B hepatitis virus. The peptide is described along with the nucleic acid which encodes this peptide, antibodies directed against the peptide, as well as vectors, host |
| 5618867 |
Hydroxy-terminated aromatic oligomeric phosphate as additive flame retardant in polycarbonate re |
April 8, 1997 |
| The present application relates to a flame retarded polycarbonate resin composition containing for flame retardancy a hydroxy-terminated aromatic oligomeric phosphate composition of the formula: ##STR1## where R is a hydrocarbyl group derived from an aliphatic or aromatic diol, A |
| 5618480 |
Process of making multifilament yarn, monofilament or film of polyethylene naphthalate |
April 8, 1997 |
| Multifilament yarn, monofilament, or film, formed at least substantially of polyethylene naphthalate, has a strength of at least 400 MN/tex and a DSC melting point of at least 292.degree. C., where the DSC melting point is measured on a sample quantity of 2.5 mg at a heating rate of 20.d |
| 5616770 |
1,4-cyclohexanedimethanol bis (diaryl phosphate) |
April 1, 1997 |
| Novel flame retardant compounds for polymers are disclosed that include 1,4-cyclohexanedimethanol bis(diphenyl phosphate)s. These can be synthesized by reacting 1,4-cyclohexanedimethanol and a diphenyl halophosphate, such as diphenyl chlorophosphate, in the presence of a catalyst, su |
| 5616685 |
snRNP-A antigen and fragments thereof |
April 1, 1997 |
| The present invention relates to a protein antigen which is reactive towards an auto-antibody which is associated with an auto-immune disease, and the use of this protein in diagnostic tests relating to auto-immune diseases. |
| 5614592 |
Filler-free peroxide masterbatch and process for making it |
March 25, 1997 |
| A process for the production of a peroxide masterbatch composition comprising the steps of: a) providing a mixture of an ethylene-propylene copolymer and 10-150 parts by weight, based on the weight of the ethylene-propylene copolymer of a polyoctenamer rubber to a mixing device, (b) |
| 5614195 |
Coccidiosis poultry vaccine |
March 25, 1997 |
| This invention relates to novel Eimeria proteins with immunogenic properties as well as to DNA sequences encoding these proteins. These proteins can be administered to poultry thereby protecting the birds against coccidiosis. In addition the DNA encoding these proteins can be used fo |
